157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. — Dinuba, California

157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. is a clinical research site located in Dinuba, California, United States 93618.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. has participated in 1 clinical trials.

Therapeutic areas: Meningitis, Meningococcal Infection.

Sponsors: Novartis.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave.?

157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. conducted?

157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. has 1 clinical trials on record. Their work covers Meningitis, Meningococcal Infection.

Is 157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. accredited by Crixeo Health?

157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 157 Universal Biopharma Research Institute Inc./Alta Family Health Clinic 888 N. Alta Ave.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.